The use of artificial intelligence (AI) to develop new drugs is in its infancy. Nevertheless, AI-designed drugs have been entering the early phases of clinical trials over the past couple of years.

Rational design, applying knowledge structure-function relationships into molecular design, has shown great promise in enzyme engineering, vaccine development, and inhibitor discovery. Using rational ...

AI is redefining how biologics are discovered, designed, and optimized—and it’s transforming what happens inside the wet lab. Today’s scientists aren’t just running experiments; they’re collaborating ...